| Literature DB >> 27373163 |
Xavier S Revelo1, Magar Ghazarian2, Melissa Hui Yen Chng3, Helen Luck2, Justin H Kim2, Kejing Zeng4, Sally Y Shi2, Sue Tsai2, Helena Lei2, Justin Kenkel3, Chih Long Liu5, Stephanie Tangsombatvisit5, Hubert Tsui6, Corneliu Sima7, Changting Xiao8, Lei Shen9, Xiaoying Li10, Tianru Jin2, Gary F Lewis8, Minna Woo11, Paul J Utz5, Michael Glogauer12, Edgar Engleman3, Shawn Winer13, Daniel A Winer14.
Abstract
Obesity-related inflammation of metabolic tissues, including visceral adipose tissue (VAT) and liver, are key factors in the development of insulin resistance (IR), though many of the contributing mechanisms remain unclear. We show that nucleic-acid-targeting pathways downstream of extracellular trap (ET) formation, unmethylated CpG DNA, or ribonucleic acids drive inflammation in IR. High-fat diet (HFD)-fed mice show increased release of ETs in VAT, decreased systemic clearance of ETs, and increased autoantibodies against conserved nuclear antigens. In HFD-fed mice, this excess of nucleic acids and related protein antigens worsens metabolic parameters through a number of mechanisms, including activation of VAT macrophages and expansion of plasmacytoid dendritic cells (pDCs) in the liver. Consistently, HFD-fed mice lacking critical responders of nucleic acid pathways, Toll-like receptors (TLR)7 and TLR9, show reduced metabolic inflammation and improved glucose homeostasis. Treatment of HFD-fed mice with inhibitors of ET formation or a TLR7/9 antagonist improves metabolic disease. These findings reveal a pathogenic role for nucleic acid targeting as a driver of metabolic inflammation in IR.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27373163 PMCID: PMC6354586 DOI: 10.1016/j.celrep.2016.06.024
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423